Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Comparison of Liver Health in Psoriatic Arthritis Patients Using Anti-TNF or Anti-IL17 Treatments
A clinical trial update comparing liver health in psoriatic arthritis patients treated with anti-TNF versus anti-IL-17 therapies; the study …
-
FDA approval · 2025-04-07FDA Approved: ADALIMUMAB — Supplemental Application (CELLTRION USA, Inc.)
FDA approved a supplemental application for ADALIMUMAB-AATY, a biosimilar adalimumab from Celltrion USA, Inc., in connection with its regula…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy [NA]
This clinical trial explores shared mechanisms contributing to non-alcoholic fatty liver disease and psoriatic arthritis severity and evalua…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: HIPPOCRATES Prospective Observational Study
HIPPOCRATES is a prospective observational study sponsored by the University of Oxford. It investigates psoriatic arthritis and psoriasis an…
-
FDA approval · 2025-04-01FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ustekinumab (Stelara) by Janssen Biotech, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Exploratory Clinical Study on Fasting in Psoriasis and Psoriatic Arthritis (RiseFast) [NA]
An exploratory clinical study called RiseFast is investigating fasting in psoriasis and psoriatic arthritis. The trial is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: WORKWELL: Testing Work Advice for People With Arthritis [NA]
Update on the WORKWELL trial evaluating work advice for people with arthritis; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis
This clinical trial update reports the completion of a study evaluating tofacitinib in people with psoriatic arthritis, with results posted.
-
FDA approval · 2025-03-26FDA Approved: RINVOQ — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Rinvoq (upadacitinib) from AbbVie, resulting in labeling changes to the product.
-
FDA label_change · 2025-03-26FDA Approved: RINVOQ — Supplemental Application (AbbVie Inc.)
FDA approved AbbVie’s supplemental application for Rinvoq (upadacitinib), resulting in a labeling update for the product.
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: A Real-World Study of Biologic Therapy for Subclinical Psoriatic Arthritis
This update reports an ongoing real-world study evaluating biologic therapies for subclinical psoriatic arthritis, with enrollment by invita…
-
CLINICAL_TRIALS research · 2025-03-17Clinical Trial Update: Psoriatic Arthritis D2P Screening [NA]
Clinical trial update indicates the Psoriatic Arthritis study (NCT04110522) is currently recruiting.
-
FDA approval · 2025-03-13FDA Approved: USTEKINUMAB-TTWE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for USTEKINUMAB-TTWE from Quallent Pharmaceuticals Health LLC, updating the product’s labeling a…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis [Phase 2]
Phase 2 clinical trial evaluating the impact of cannabis on pain and inflammation in rheumatoid arthritis and psoriatic arthritis. The study…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Card14gene (rs34367357 ) Polymorphism in Egyptian Psoriatic and Psoriatic Arthritis Patient [NA]
A clinical trial in Egypt is recruiting to study the Card14 gene polymorphism rs34367357 in patients with Psoriatic Arthritis.
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Construct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic Disease
A completed study evaluating the construct validity and responsiveness of the EQ-5D-3L health-status instrument in patients with rheumatic d…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Serum, Cellular and Imaging Markers of Arthritis in Psoriasis Patients
A completed clinical trial investigating serum, cellular, and imaging biomarkers of arthritis in psoriasis patients.
-
EMA approval · 2025-03-03EMA Authorised: Nepexto (etanercept) — Biosimilar Collaborations Ireland Limited
EMA authorised Nepexto, a biosimilar of etanercept, developed by Biosimilar Collaborations Ireland Limited, for several inflammatory arthrit…
-
FDA approval · 2025-02-26FDA Approved: CELECOXIB — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for Celecoxib (celecoxib), authorizing a generic version under the ANDA pathway. The ac…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Quantitative Ultrasound of the Enthesis in Fibromyalgia and Psoriatic Arthritis
The clinical trial evaluating quantitative ultrasound of the enthesis in fibromyalgia and psoriatic arthritis has been terminated.
-
FDA approval · 2025-02-21FDA Approved: XELJANZ XR — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XELJANZ XR (tofacitinib) submitted by Pfizer, updating the extended-release formulation's label.
-
CLINICAL_TRIALS withdrawal · 2025-02-13Clinical Trial Update: Enhanced Clinics for Patients Diagnosed With Ankylosing Spondylitis and Psoriatic Arthritis
The trial evaluating enhanced clinics for patients with ankylosing spondylitis and psoriatic arthritis has been withdrawn.
-
FDA approval · 2025-02-12FDA Approved: SELARSDI — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for SELARSDI (ustekinumab-aeKn) from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) Therapy [Phase 3]
Phase 3 study evaluating guselkumab in adults with active psoriatic arthritis and inadequate response to anti-TNF therapy has completed.
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis
A completed analysis of birth outcomes among Swedish, Danish, and Finnish women exposed to Remicade (infliximab) during pregnancy across inf…